
Vaibhavi M. | Dec 06, 2025

Ravindra Warang | Jun 23, 2025

Ravindra Warang | Jun 21, 2025
India is transitioning from generics dominance to a global biologics and biosimilars leader, shaping the future of advanced therapies.

Automation and robotics are transforming API manufacturing with better safety, precision, and efficiency across hazardous steps.

India’s PLI scheme is rebuilding API manufacturing with local capacity, tech upgrades, and reduced import dependence.

How India’s PLI scheme is rebuilding API manufacturing, strengthening supply chains, and reducing import dependence.

How KSM clusters drive SME growth, lower costs, and build resilient pharma supply chains.
